Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

The Microbiome in Pediatric Rheumatic Diseases

Matthew Stoll, MD, PhD  |  Issue: April 2016  |  April 15, 2016

Antibiotics: Another shotgun approach to altering the gut microbiota in rheumatic disease is the use of antibiotics. However, antibiotics may be a double-edged sword with respect to inflammatory arthritis. Several recent studies evaluating large European databases have shown that early use of antibiotics may be a risk factor for subsequent development of pediatric IBD and JIA.35-38 However, although antibiotics don’t appear to be effective in SpA, studies of their effect in adult RA patients have demonstrated success.39,40

The microbial counterpart to a deep bench is high alpha diversity, which is a measure of the richness, as well as the evenness, of the organisms present in a community. Specifically, richness speaks to the number of different organisms, while evenness speaks to their distribution. Thus, a balanced & diverse microbiota may be optimal for maintaining health.

It’s hard to imagine that a disease potentially caused by antibiotics (e.g., JIA) could then be treated by antibiotics. Moreover, the risks of long-term antibiotic use, such as infection with C. difficile, also discourage their use. Further, antibiotics are fairly indiscriminate in their effect on the microbiota, wiping out both beneficial and harmful organisms and undoubtedly adversely affecting diversity. There has been very little interest in their use in the biologic era, and at present, it is difficult to propose introducing them as part of the therapeutic armamentarium for children with JIA. However, the positive results of some of the studies in using antibiotics to treat rheumatic disorders speak to the potential of therapeutic alterations of the microbiome.

Diet: Perhaps, a safer approach to altering gut microbiota involves dietary changes. That dietary changes can rapidly effect alterations in the microbiome is well established. For example, the study by Wu and colleagues also involved an interventional arm, in which 10 subjects were randomized to either a low-fat or a high-fat diet for 10 days, with substantial changes seen in some subjects after just one day.10 In light of the typical American diet, the changes appeared to be more pronounced among those randomized to the low-fat diet compared with those randomized to the high-fat diet.

Figure 2: Illustration of the concepts of richness and evenness within alpha diversity. Richness refers to the variety of different organisms; evenness refers to the distribution of the organisms within the population.

Figure 2: Illustration of the concepts of richness and evenness within alpha diversity. Richness refers to the variety of different organisms; evenness refers to the distribution of the organisms within the population.

An extreme form of dietary change consists of exclusive enteral nutrition (EEN), which appears to be comparable to corticosteroids as induction therapy in pediatric IBD.41 On the other hand, dietary interventions in RA have not been particularly effective.42 There are no data in children, aside from a case report of EEN benefit in a child with refractory polyarticular JIA.43 It must be emphasized that just because a particular diet may alter the microbiota, it does not follow that this alteration is beneficial with respect to any particular disease process. In addition, many diets may be very difficult to sustain. The challenge will be in identifying a diet that promotes beneficial changes in the microbiota, provides appropriate balanced nutrition and is acceptable to families for the long term.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Page: 1 2 3 4 5 6 7 8 | Single Page
Share: 

Filed under:ConditionsPediatric ConditionsResearch Rheum Tagged with:gastrointestinal diseasejuvenile rheumatoid arthritisMicrobiomemicrobiotiaPediatricResearchRheumatic Disease

Related Articles

    Research Provides Insight into Impact of Microbiome on Health, Rheumatic Disease

    April 15, 2016

    The microbiome comprises diverse microbial flora, including bacteria, viruses and fungi, that live on mucosal surfaces, predominantly the skin and digestive tract. Microbes evolved billions of years prior to the development of modern Homo sapiens 200,000 years ago; we have always existed with their ubiquitous presence. Despite this, the first microbe was not visualized until…

    Links Between Gut Bacteria and Rheumatoid Arthritis

    March 19, 2019

    CHICAGO—At the 2018 ACR/ARHP Annual Meeting, Allen C. Steere, MD, delivered the Rheumatology Research Foundation Memorial Lecture honoring the late Charles M. Plotz, MD: Linking Gut Microbial Immunity with Autoimmunity in Joints in Patients with Rheumatoid Arthritis. Dr. Steere is professor of medicine at Harvard Medical School, Boston, and director of translational research in rheumatology…

    The Microbiome

    November 1, 2011

    A voyage to (our inner) Lilliput

    2014 ACR/ARHP Annual Meeting: Microbiota Power

    March 1, 2015

    Gut bacteria may hold clues to breakthrough rheumatic disease treatments

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences